

NCT02668016 comparison:

Summary:
CHIA has 17 criteria while your personal folder has 17 criteria
Total found criteria: 17/17
Total not Found: 0/17
Total Extra: 1
This trial is VALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ Aged 18 years or older                             │ Aged 18 years or older                             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Previously taken one or more statins               │ Previously taken one or more statins               │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Withdrawn from statins because of perceived side   │ Withdrawn from statins because of perceived side   │
│ effects                                            │ effects                                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Developed side effects within 2 weeks of           │ Developed side effects within 2 weeks of           │
│ initiation                                         │ initiation                                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Clinical indication for statins for primary or     │ Clinical indication for statins for primary or     │
│ secondary prevention of cardiovascular disease or  │ secondary prevention of cardiovascular disease or  │
│ dyslipidaemia, on either no medication or non-     │ dyslipidaemia, on either no medication or non-     │
│ statin lipid lowering therapy (e.g, ezetimibe)     │ statin lipid lowering therapy (e.g, ezetimibe)     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ History of neuropathy                              │ History of neuropathy                              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Regularly taking prescribed analgesia              │ Regularly taking prescribed analgesia              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ History of a chronic pain condition                │ History of a chronic pain condition                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ History of severe mental illness (as their         │ History of severe mental illness (as their         │
│ experience of symptoms may already be altered)     │ experience of symptoms may already be altered)     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Current use of fibrates (because of the risk of    │ Current use of fibrates (because of the risk of    │
│ interaction with statins but will not exclude      │ interaction with statins but will not exclude      │
│ participants taking ezetimibe)                     │ participants taking ezetimibe)                     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Severe previous reaction or reaction considered    │ Severe previous reaction or reaction considered    │
│ immunological, such as anaphylaxis, facial         │ immunological, such as anaphylaxis, facial         │
│ swelling, severe rash, muscle ache with rise in    │ swelling, severe rash, muscle ache with rise in    │
│ serum creatine kinase, inflammatory myopathy,      │ serum creatine kinase, inflammatory myopathy,      │
│ rhabdomyolysis or liver function abnormalities     │ rhabdomyolysis or liver function abnormalities     │
│ (aspartate transaminase (AST) or alanine           │ (aspartate transaminase (AST) or alanine           │
│ transaminase (ALT) greater than 3 times upper      │ transaminase (ALT) greater than 3 times upper      │
│ limit or normal)                                   │ limit or normal)                                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Side-effects taking longer than 2 weeks to develop │ Side-effects taking longer than 2 weeks to develop │
│ (because in such participants much longer blocks   │ (because in such participants much longer blocks   │
│ of treatment would be required, if the present     │ of treatment would be required, if the present     │
│ study is positive such studies will be planned for │ study is positive such studies will be planned for │
│ the future)*                                       │ the future)\*                                      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ History of statin intolerance with drug            │ History of statin intolerance with drug            │
│ interaction to antiretroviral drugs                │ interaction to antiretroviral drugs                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ History of statin intolerance to any other drug    │ History of statin intolerance to any other drug    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Pregnant or breast feeding                         │ Pregnant or breast feeding                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Side effects taking longer than 2 weeks to present │ Side effects taking longer than 2 weeks to present │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ In clinical judgement of study doctor, participant │ In clinical judgement of study doctor, participant │
│ should not participate                             │ should not participate                             │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



Everything was Found



╒═══════════════════════════════════╕
│ Extra Personal Criteria           │
╞═══════════════════════════════════╡
│ Must have minimum age of 18 Years │
╘═══════════════════════════════════╛